Are we aiming to miss in translational autoimmunity treatments? [version 1; referees: 2 approved, 1 approved with reservations]

Autoimmunity treatments, fruitfully pioneered in mouse models, can be disappointing or result in immunosuppression and opportunistic infections in translational trials. Many possible reasons exist, but one major, overlooked reason may be the treatment timing in relation to circadian oscillations of...

Full description

Bibliographic Details
Main Authors: Gisela M. Vaitaitis, David H. Wagner
Format: Article
Language:English
Published: F1000 Research Ltd 2018-11-01
Series:F1000Research
Online Access:https://f1000research.com/articles/7-1754/v1